comparemela.com
Home
Live Updates
Phase 3 Alina Study - Breaking News
Pages:
Latest Breaking News On - Phase 3 alina study - Page 1 : comparemela.com
FDA Grants Priority Review to Adjuvant Alectinib for Early-Stage ALK+ NSCLC
The FDA granted priority review to a sBLA seeking the approval of alectinib as adjuvant treatment after surgery for early-stage ALK-positive NSCLC.
Non small cell lung cancer
Alk positive non small cell lung cancer
Priority review
Phase 3 alina study
Adjuvant treatment after surgery
vimarsana © 2020. All Rights Reserved.